Cargando…
Non-pharmaceutical interventions to optimize cancer immunotherapy
The traditional picture of cancer patients as weak individuals requiring maximum rest and protection is beginning to dissolve. Too much focus on the medical side and one’s own vulnerability and mortality might be counterproductive and not doing justice to the complexity of human nature. Unlike cytot...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543347/ https://www.ncbi.nlm.nih.gov/pubmed/37791231 http://dx.doi.org/10.1080/2162402X.2023.2255459 |
_version_ | 1785114282431610880 |
---|---|
author | Boesch, Maximilian Baty, Florent Rassouli, Frank Kowatsch, Tobias Joerger, Markus Früh, Martin Brutsche, Martin H. |
author_facet | Boesch, Maximilian Baty, Florent Rassouli, Frank Kowatsch, Tobias Joerger, Markus Früh, Martin Brutsche, Martin H. |
author_sort | Boesch, Maximilian |
collection | PubMed |
description | The traditional picture of cancer patients as weak individuals requiring maximum rest and protection is beginning to dissolve. Too much focus on the medical side and one’s own vulnerability and mortality might be counterproductive and not doing justice to the complexity of human nature. Unlike cytotoxic and lympho-depleting treatments, immune-engaging therapies strengthen the immune system and are typically less harmful for patients. Thus, cancer patients receiving checkpoint inhibitors are not viewed as being vulnerable per se, at least not in immunological and physical terms. This perspective article advocates a holistic approach to cancer immunotherapy, with an empowered patient in the center, focusing on personal resources and receiving domain-specific support from healthcare professionals. It summarizes recent evidence on non-pharmaceutical interventions to enhance the efficacy of immune checkpoint blockade and improve quality of life. These interventions target behavioral factors such as diet, physical activity, stress management, circadian timing of checkpoint inhibitor infusion, and waiving unnecessary co-medication curtailing immunotherapy efficacy. Non-pharmaceutical interventions are universally accessible, broadly applicable, instantly actionable, scalable, and economically sustainable, creating value for all stakeholders involved. Most importantly, this holistic framework re-emphasizes the patient as a whole and harnesses the full potential of anticancer immunity and checkpoint blockade, potentially leading to survival benefits. Digital therapeutics are proposed to accompany the patients on their mission toward change in lifestyle-related behaviors for creating optimal conditions for treatment efficacy and personal growth. |
format | Online Article Text |
id | pubmed-10543347 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-105433472023-10-03 Non-pharmaceutical interventions to optimize cancer immunotherapy Boesch, Maximilian Baty, Florent Rassouli, Frank Kowatsch, Tobias Joerger, Markus Früh, Martin Brutsche, Martin H. Oncoimmunology Review The traditional picture of cancer patients as weak individuals requiring maximum rest and protection is beginning to dissolve. Too much focus on the medical side and one’s own vulnerability and mortality might be counterproductive and not doing justice to the complexity of human nature. Unlike cytotoxic and lympho-depleting treatments, immune-engaging therapies strengthen the immune system and are typically less harmful for patients. Thus, cancer patients receiving checkpoint inhibitors are not viewed as being vulnerable per se, at least not in immunological and physical terms. This perspective article advocates a holistic approach to cancer immunotherapy, with an empowered patient in the center, focusing on personal resources and receiving domain-specific support from healthcare professionals. It summarizes recent evidence on non-pharmaceutical interventions to enhance the efficacy of immune checkpoint blockade and improve quality of life. These interventions target behavioral factors such as diet, physical activity, stress management, circadian timing of checkpoint inhibitor infusion, and waiving unnecessary co-medication curtailing immunotherapy efficacy. Non-pharmaceutical interventions are universally accessible, broadly applicable, instantly actionable, scalable, and economically sustainable, creating value for all stakeholders involved. Most importantly, this holistic framework re-emphasizes the patient as a whole and harnesses the full potential of anticancer immunity and checkpoint blockade, potentially leading to survival benefits. Digital therapeutics are proposed to accompany the patients on their mission toward change in lifestyle-related behaviors for creating optimal conditions for treatment efficacy and personal growth. Taylor & Francis 2023-09-28 /pmc/articles/PMC10543347/ /pubmed/37791231 http://dx.doi.org/10.1080/2162402X.2023.2255459 Text en © 2023 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent. |
spellingShingle | Review Boesch, Maximilian Baty, Florent Rassouli, Frank Kowatsch, Tobias Joerger, Markus Früh, Martin Brutsche, Martin H. Non-pharmaceutical interventions to optimize cancer immunotherapy |
title | Non-pharmaceutical interventions to optimize cancer immunotherapy |
title_full | Non-pharmaceutical interventions to optimize cancer immunotherapy |
title_fullStr | Non-pharmaceutical interventions to optimize cancer immunotherapy |
title_full_unstemmed | Non-pharmaceutical interventions to optimize cancer immunotherapy |
title_short | Non-pharmaceutical interventions to optimize cancer immunotherapy |
title_sort | non-pharmaceutical interventions to optimize cancer immunotherapy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543347/ https://www.ncbi.nlm.nih.gov/pubmed/37791231 http://dx.doi.org/10.1080/2162402X.2023.2255459 |
work_keys_str_mv | AT boeschmaximilian nonpharmaceuticalinterventionstooptimizecancerimmunotherapy AT batyflorent nonpharmaceuticalinterventionstooptimizecancerimmunotherapy AT rassoulifrank nonpharmaceuticalinterventionstooptimizecancerimmunotherapy AT kowatschtobias nonpharmaceuticalinterventionstooptimizecancerimmunotherapy AT joergermarkus nonpharmaceuticalinterventionstooptimizecancerimmunotherapy AT fruhmartin nonpharmaceuticalinterventionstooptimizecancerimmunotherapy AT brutschemartinh nonpharmaceuticalinterventionstooptimizecancerimmunotherapy |